Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | CNR1 | P21554 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29384019 | 0.98 | MCL1 (0.53) | ALDH1A1MCL1TSHRL3MBTL1HPGD | |
| SCHEMBL198460 | 0.98 | MCL1 (0.53) | ALDH1A1MCL1TSHRL3MBTL1HPGD | |
| Hydrochloric Acid SCHEMBL8922332 | 0.96 | ALDH1A1 (0.52) | ALDH1A1MCL1TSHRL3MBTL1HPGD | |
| SCHEMBL3695138 | 0.96 | ALDH1A1 (0.52) | ALDH1A1MCL1TSHRL3MBTL1HPGD | |
| SCHEMBL3009009 | 0.96 | ALDH1A1 (0.52) | ALDH1A1MCL1TSHRL3MBTL1HPGD | |
| SCHEMBL5078515 | 0.96 | ALDH1A1 (0.52) | ALDH1A1MCL1TSHRL3MBTL1HPGD | |
| Hydrochloric Acid SCHEMBL11157085 | 0.96 | ALDH1A1 (0.52) | ALDH1A1MCL1TSHRL3MBTL1HPGD | |
| SCHEMBL78762 | 0.96 | ALDH1A1 (0.52) | ALDH1A1MCL1TSHRL3MBTL1HPGD | |
| Water SCHEMBL31261447 | 0.96 | ALDH1A1 (0.52) | ALDH1A1MCL1TSHRL3MBTL1HPGD | |
| Water SCHEMBL28663433 | 0.96 | ALDH1A1 (0.52) | ALDH1A1MCL1TSHRL3MBTL1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8128836-B2 | Electrolyte membrane and method of selecting the same | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2012-03-06 | — | — | US | disclosed |
| US-20110190309-A1 | PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A Beta2-ADRENOCEPTOR AGONIST | PULMAGEN THERAPEUTICS (SYNERGY) LIMITED (GB) | 2011-08-04 | — | — | US | disclosed |
| EP-2315589-A1 | PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A beta2-ADRENOCEPTOR AGONIST | AstraZeneca AB (SE) | 2011-05-04 | — | — | EP | disclosed |
| WO-2009139708-A1 | PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A β2-ADRENOCEPTOR AGONIST | ASTRAZENECA AB (SE) | 2009-11-19 | — | — | WO | disclosed |
| WO-2009139707-A1 | PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A SECOND ACTIVE INGREDIENT | ASTRAZENECA AB (SE) | 2009-11-19 | — | — | WO | disclosed |
| US-20090166579-A1 | Electrolyte Membrane and Method of Selecting the Same | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2009-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110190309-A1 | PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A Beta2-ADRENOCEPTOR AGONIST | ADRB2, ADRB1, ADRA2A | ALDH1A1 1393/4885MCL1 4598/4885TSHR 341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.